Techniques and results of direct-access minimally invasive mitral valve surgery: A paradigm for the future  by Aklog, Lishan et al.
pain, reduce morbidity, shorten recovery time, and
decrease costs while achieving a superior cosmetic
result and improved patient satisfaction. Minimally
invasive valve surgery, particularly mitral surgery, has
been less widely performed but is increasingly signifi-
cant. A variety of approaches have been reported,
including Port-Access techniques,1,2 videoscopic tech-
niques,3-6 various types of partial sternotomy,7-12 and
the parasternal approach.13-17
In August 1996 we initiated a minimally invasive
direct-access mitral valve surgery program using a
parasternal approach originally suggested by Navia and
Cosgrove.13 Our goal was to develop a system to per-
form primary mitral valve surgery that fulfilled the fol-
lowing requirements:
1. A significantly smaller incision, with minimal dis-
ruption of the chest wall
T he field of minimally invasive cardiac surgery hasgrown rapidly in recent years. Although diverse
techniques and philosophies have emerged, these tech-
niques share the common goal of decreasing surgical
trauma while maintaining surgical efficacy. If success-
ful, this reduction in surgical trauma should decrease
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2. A safe and reproducible approach to cardiopul-
monary bypass (CPB) and myocardial protection
3. Applicability to the majority of patients with iso-
lated mitral valve disease
4. Adequate visualization to allow standard valve
repair and replacement by means of conventional tech-
niques and instruments
5. Equal to the safety and efficacy of conventional
mitral valve surgery
In this report we review our techniques and results
with this approach to assess the extent to which we
have accomplished these goals.
Methods
Patient population. Between August 1, 1996, and January
1, 1998, 109 patients underwent direct-access minimally
invasive mitral valve surgery through a right parasternal inci-
sion at Brigham and Women’s Hospital. For the purposes of
this analysis, the 3 patients who underwent concomitant sin-
gle coronary artery bypass, subaortic reconstruction, or reop-
erative surgery were excluded, leaving 106 patients in the
study group. Five patients who underwent minor secondary
procedures through the right atrium (3 atrial septal defect
repairs and 3 tricuspid annuloplasties) were included. Three
patients had undergone closed mitral commissurotomy (n = 2)
or balloon valvuloplasty (n = 1). Of these 106 patients, 90
underwent mitral valve repair and 16 underwent mitral valve
replacement. Preoperative characteristics of the patients are
shown in Table I.
Patient characteristics. The majority of patients had
severe, chronic mitral regurgitation whereas a smaller number
had pure mitral stenosis or a mixed picture of both regurgita-
tion and stenosis. The most common pathologic findings were
myxomatous degeneration, rheumatic disease, and endocardi-
tis. Almost all patients had New York Heart Association class
II or III symptoms. Left ventricular function was good or only
mildly depressed in most patients. The majority were in nor-
mal sinus rhythm, but a significant minority had atrial fibril-
lation before the operation. All patients more than 50 years old
underwent coronary angiography; significant multivessel
coronary artery disease was a contraindication to the mini-
mally invasive approach. A few patients in each group had
mild coronary artery disease and 3 patients had preoperative
percutaneous transluminal angioplasty. 
Operative techniques
Preoperative preparation. The patient’s body habitus and
chest x-ray film were carefully reviewed before a minimally
invasive approach was undertaken. Obtaining adequate expo-
sure can be difficult in markedly obese patients, patients with
significant chest wall abnormalities (pectus excavatum, deep
anteroposterior diameter), and those with unusual cardiac ori-
entation (extremely vertical or horizontal, leftward shift).
Transesophageal echocardiography (TEE) was used in all
patients and is essential in guiding cannulation, recovering
intracardiac air, and in assessing the technical result. A pul-
monary artery catheter was inserted in 53% of patients but in
only 20% over the last 3 months. Its use is now limited to
elderly patients, those with decreased left ventricular function,
and those with severe pulmonary hypertension.
Transcutaneous defibrillator pads were placed on all patients.
Incision. A 5- to 8-cm vertical incision was made along the
right edge of the sternum. Assessing the position of the right
atrium and ascending aorta relative to the intercostal spaces
on the chest x-ray film is critical. Typically, the pericardial
space is first entered through a smaller incision directly over
the third costal cartilage. This incision is then extended over
the second or fourth cartilage depending on the patient’s
anatomy. Although this approach usually led to resection of
the third and fourth cartilages, a large number of patients
have had the second and third cartilages resected as we have
moved to direct aortic cannulation in recent months.
Dissecting the pectoralis major muscle off its sternal inser-
tion, mobilizing it widely off the chest wall, greatly aids in
the exposure. A 1- to 2-cm section of each costal cartilage is
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Table I. Preoperative patient characteristics
Minimally invasive surgery 
(n = 106)
No. %
Age (yr)
Mean 58.1.± 12.7
Range 22-83
Male/female 62/44
NYHA functional class 2.3 ± 0.5
Mitral valve pathophysiology
Mitral regurgitation 93 88
Mitral stenosis 4 4
Mixed 9 8
Mitral valve pathology
Myxomatous 83 78
Rheumatic 15 14
Endocarditis 5 5
Congenital 2 2
Ischemic 1 1
Procedure
Mitral valve repair 90 85
Mitral valve replacement 16 15
Left ventricular function
Mean ejection fraction 61% ± 12%
Good (>50%) 93 87
Mild dysfunction (40%-50%) 9 9
Moderate dysfunction (30%-40%) 3 3
Severe dysfunction (<30%) 1 1
Preoperative rhythm
Normal sinus rhythm 62 58
Atrial fibrillation 43 41
Paced 1 1
Coronary artery disease
None 91 86
One- to two-vessel, no intervention 6 5.5
One- to two-vessel, preop PTCA 2 2
Coronary angiogram not done 7 6.5
NYHA, New York Heart Association; PTCA, percutaneous transluminal
coronary angioplasty.
excised at the sternocostal junction. The right internal tho-
racic pedicle is then divided at the upper and lower inter-
costal spaces, and the intercostal muscles are incised 3 to 4
cm lateral to the thoracic pedicle. These maneuvers allow the
detached ribs to be retracted laterally like an open book and
minimize the amount of cartilage resection necessary to ob-
tain adequate exposure. The right pleural space is entered to
prevent postoperative pericardial effusions. The pericardium
is incised parallel to the phrenic nerve and marsupialized by
securing it to the skin with multiple retraction sutures to pull
the heart slightly to the right of midline and into the field.
CPB. The majority of patients (85%) were supported with
CPB by means of femoral cannulation through a small (2 to
4 cm) oblique incision above and parallel to the groin crease.
The most common cannulas included a 20F cannula (Sarns,
Inc, Ann Arbor, Mich) in the right femoral artery, a long 23F
to 27F Bio-Medicus cannula (Medtronic Bio-Medicus, Eden
Prairie, Minn) inserted into the inferior vena cava through the
right femoral vein, and a 24F right-angled cannula (Research
Medical, Midvale, Utah) inserted directly into the superior
vena cava. The femoral vein cannula was placed through a
purse-string suture at the sapheno-femoral junction without
clamping the vein.
Two recent developments have allowed us to avoid a groin
incision in the majority of patients (11 of the last 16 patients).
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Fig 1. Current cannulation setup for minimally invasive
mitral valve surgery. A, Right parasternal incision over third
and fourth costal cartilages. Venous drainage through a per-
cutaneous right femoral venous cannula and a superior vena
cava cannula. Arterial perfusion through an extended aortic
cannula passing through a stab incision into the aorta, posi-
tioned in the distal arch. B, Exposure of right atrium after
completion of cannulation, placement of aortic crossclamp,
initiation of antegrade cardioplegia, and securing of tourni-
quets around inferior and superior venae cavae (IVC and
SVC, respectively).
Fig 2. Right atriotomy after completion of cardioplegia. SVC,
Superior vena cava.
Fig 3. Atrial septotomy after completion of right atriotomy
and retraction of cut edges of right atrium with multiple
retraction sutures. Optional direct insertion of coronary sinus
catheter also shown. Lower panel, Exposure of mitral valve
after completion of atrial septotomy and retraction of cut
edges of atrial septum with multiple retraction sutures.
This alternative cannulation technique is depicted in Fig 1.
The ascending aorta is cannulated, by means of a modified
Seldinger technique, with a 20F elongated, thin-walled arter-
ial cannula equipped with a finely tapered but pliable dilator
(Medtronic DLP, Grand Rapids, Mich). The wire and cannu-
la tip are positioned in the distal aortic arch by TEE. A 21F
percutaneous Bio-Medicus cannula is inserted through the
femoral vein and guided into the inferior vena cava by TEE.
Vacuum-assisted venous drainage has enabled us to use sig-
nificantly smaller cannulas even in relatively large patients,
protecting the exposure by using the smallest possible cannu-
las and tourniquets and passing them through separate stab
incisions (future chest tube sites).
All patients received intermittent antegrade infusions of cold
blood cardioplegic solution. Some patients (24%) received
additional retrograde infusions of cardioplegic solution, usually
by cannulating the coronary sinus under direct vision.
Moderate systemic hypothermia (25°C-30°C) was generally
used to provide an added measure of myocardial protection.
Mitral valve exposure. The mitral valve was exposed
through the right atrium and atrial septum in the majority
(76%) of patients (Figs 2 and 3). Multiple retraction sutures
were placed, first on the right atrial incision and then on the
septal edges, to gradually obtain exposure of the valve. Placing
some or all of the annuloplasty sutures at the outset greatly
improves valve exposure by bringing the anulus rightward and
into the field. In the remaining patients, generally those with
large left atria, the valve was approached directly through the
left atrium after dissection of Sondergaard’s groove. With
either approach, the atrial septum was retracted anteriorly and
to the left by means of a blade from the Cosgrove mitral valve
retraction system (Baxter Healthcare Corp, Santa Ana, Calif)
attached to the articulating arm of a Thompson retractor. Mitral
valve repair or replacement was performed with the use of
standard instruments and techniques.
Closure. The atrial septotomy and right atriotomy were
then closed. A ventricular pacing wire was placed on the right
ventricle while the heart was still empty, before the cross-
clamp had been removed. Careful complete evacuation of
intracardiac air was performed through the left atrium and
aortic root and confirmed by TEE. After termination of CPB,
the incision was closed by carefully reapproximating the pec-
toralis major muscle back to the sternum. Paying careful
attention to this maneuver and limiting the amount of resect-
ed cartilage appear to have eliminated most problems with
lung herniation through the parasternal incision. Two small
right-angled chest drains were placed through previously
placed stab incisions and connected to underwater suction.
Postoperative care. Most patients were extubated in the
intensive care unit and transferred to a monitored step-down
unit on postoperative day 1 with the goal of discharge by
postoperative day 3 to 5. All patients without contraindica-
tions to b -blockers were started on a program of metoprolol
for prophylaxis against atrial fibrillation. Patients with new
atrial fibrillation were generally discharged on a regimen of
warfarin once adequate rate control had been achieved. All
patients underwent transthoracic echocardiography before
discharge.
Data collection and analysis. Postoperative follow-up
included a 6-week postoperative visit and annual follow-up
visits including serial echocardiography when possible.
Further follow-up was obtained through telephone calls to
every patient during March 1998. Preoperative, operative,
and postoperative data were prospectively collected and
stored in our division’s cardiac surgery database. Hospital
charges were adjusted to constant 1998 dollars by means of
the annual rate of increase of charges at our hospital.
Data were tabulated with the use of Microsoft Excel
and statistical analysis was performed by means of the
Prophet statistical package (BBN Systems & Technologies,
Cambridge, Mass). Means are reported along with the stan-
dard deviation. Means were compared by use of an unpaired
Student t test when the sample passed the normality test.
Otherwise, a 2-sample Mann-Whitney rank sum test (2-sided)
was used to compare the medians of the samples. Proportions
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Fig 4. Demonstration of proportion of primary (without coronary artery bypass grafting) mitral valve operations
at Brigham and Women’s Hospital performed by conventional and minimally invasive techniques (August 1996
to December 1997).
were compared with the use of Fisher’s exact test for 2-by-2
contingency tables and c 2 analysis for larger tables.
Results
During the study period (August 1, 1996, to January
1, 1998), 106 patients underwent minimally invasive
mitral valve surgery (MI-MVS group) and 22 patients
underwent conventional primary, isolated mitral valve
surgery through a full sternotomy (control group).
Hence minimally invasive operations represented 83%
of all primary, isolated mitral valve procedures during
this period. This proportion increased from 57% for the
second half of 1996 to 87% during 1997 (Fig 4).
Operative and postoperative data. Specific opera-
tive techniques of mitral valve repair and replacement
including CPB data are summarized in Tables II and
III. Most patients having mitral valve repair underwent
posterior leaflet resection with leaflet advancement and
ring annuloplasty. The mean ischemic and CPB times
were generally about 25% higher than those needed for
conventional mitral valve surgery. Early postoperative
data are summarized in Tables IV to VI. Duration of
ventilatory support and intensive care unit stay was 8.9
± 74 hours and 31 ± 37 hours, respectively, for patients
having minimally invasive mitral valve surgery (MI-
MVS group). In a comparison group having conven-
tional mitral valve surgery (control group), nearly
twice as many patients required extended ventilatory
support of greater than 12 hours and extended intensive
care unit stay of greater than 48 hours.
Blood product use. The number of patients requiring
no red blood cell transfusions was 67 of 106 (63%) and
the mean number of units transfused was 0.9 ± 22
units. Only 3 (3%) required more than 4 transfusions
(Table III).
Pain control. In-hospital pain control was roughly
assessed by tabulating the number of milligrams of mor-
phine and tablets of acetaminophen/oxycodone hydro-
chloride (Percocet; DuPont Merck Pharmaceutical
Company) that were administered within the first 3 post-
operative days. The MI-MVS group required 24% less
morphine and 34% less acetaminophen/oxycodone
hydrochloride (Percocet) than other patients undergoing
sternotomy in our experience. Pain control after discharge
was assessed according to the degree to which the patients
took advantage of their Percocet prescription. Fewer than
5% of patients completed their initial prescription and
about 50% of patients in the MI-MVS group reported that
they never even filled the initial pain medicine prescrip-
tion.
Hospital charges. Mean hospital charges, expressed
The Journal of Thoracic and
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Table II. Operative techniques (n = 106)
No. %
Incision
Parasternal 106 100
Conversion to sternotomy 0
Mitral valve exposure
Right atriotomy and atrial septotomy 80 75
Left atriotomy through interatrial groove 26 25
CPB
Arterial cannulation
Femoral artery 87 82
Aorta 19 18
Venous cannulation
Right atrium/SVC 5 5
Femoral vein (open)/SVC 89 84
Femoral vein (closed)/SVC 12 11
Cardioplegia
Antegrade only 81 76
Antegrade/retrograde 25 24
CPB, Cardiopulmonary bypass; SVC, superior vena cava.
Table III. Operative procedures (n = 106)
No. %
Mitral valve repair 90 84
Posterior leaflet resection 83 92
and sliding valvuloplasty
Commissuroplasty 12 13
Chordoplasty 5 6
Anterior leaflet resection 1 1
Commissurotomy 1 1
Cleft closure 2 2
Decalcification 4 4
Ring annuloplasty*
Cosgrove-Edwards ring 83 92
Carpentier-Edwards ring 3 3
Duran ring 0 0
None 4 4
Mitral valve replacement* 16 15
St Jude Medical 12 75
Hancock 3 19
Carpentier-Edwards 1 6
Secondary procedures 6 6
Atrial septal defect 3 50
Tricuspid annuloplasty 3 50
Operative times (min)
Ischemic (crossclamp)
Mean 102 ± 35
Median 91.5
CPB
Mean 152 ± 43
Median 142.5
Red blood cell transfusion
Mean (units) 0.9 ± 2.2
None 67 63
>4 units 3 3
*Baxter Healthcare Corp, Edwards Division, Santa Ana, Calif; Medtronic,
Inc, Minneapolis, Minn; St Jude Medical, Inc, St Paul, Minn.
in constant 1998 dollars, were about $41,000.00. New
atrial fibrillation had a major impact on hospital
charges, as it did on length of stay, increasing charges
by $8843.
Early morbidity and mortality. Early postoperative
morbidity and mortality for the MI-MVS group are
shown in Table IV.
Operative mortality. There were no operative deaths
in the MI-MVS group.
Cardiac morbidity. Low cardiac output necessitating
moderate inotropic support (dopamine >5 m g/kg per
minute) occurred in only 1 patient. No myocardial
infarctions developed. One patient, without significant
coronary artery disease, required placement of an intra-
aortic balloon pump for severe, persistent ischemic
changes after being weaned from CPB. These changes
resolved completely within 24 hours, without definite
chemical, electrocardiographic, or echocardiographic
evidence of myocardial infarction. New postoperative
atrial fibrillation occurred in 27% of those patients who
had normal sinus rhythm on admission. In only 1 of
these patients had normal sinus rhythm not been
restored by the 6-week postoperative visit. One patient
required placement of a permanent pacemaker for post-
operative complete heart block. Three patients had
pericardial effusions that required operative (n = 2) or
percutaneous drainage (n = 1).
Wound problems. No patient required conversion to
sternotomy and none had a deep sternal infection. Three
had superficial chest wound infections: two responded to
outpatient antibiotic therapy and 1 required readmission
for intravenous antibiotics. Nineteen patients reported
mild bulging at their parasternal incision with coughing.
Most of these patients were relatively thin, small women,
relatively early in our experience. Only 1 of these patients
reported this to be a significant problem; the rest remained
very satisfied with their choice of a minimally invasive
incision. None has required operative intervention.
Four patients had minor groin wound problems
including superficial wound infections, seromas, and
small hematomas, all of which resolved with conserva-
tive treatment. One patient had a lymphocele that ulti-
mately required surgical repair. One patient had
femoral neuropathy, which resolved completely.
Vascular problems. Six patients (5.7%) had vascular
problems related to femoral cannulation. Five patients
had localized femoral artery injury that was repaired
with endarterectomy, primary repair, or Dacron patch
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Table IV. Operative mortality and morbidity (n = 106)
No. %
Operative deaths 0 0
Cardiac morbidity
New atrial fibrillation 17 27
Reverted to NSR by 6 wk 16 94
New permanent pacemaker 1 0.9
Inotropic support 1 0.9
IABP 1 0.9
Myocardial infarction 0 0.0
Pericardial effusion necessitating drainage 3 2.8
Other morbidity
Re-exploration for bleeding 1 0.9
Neurologic events
Transient ischemic attack 2 1.9
Stroke 1 0.9
Wound problems
Chest
Deep infection 0 0
Superficial infection 3 0.9
Herniation (troublesome) 1 0.9
Groin
Major (lymphocele) 1 0.9
Minor 4 3.7
Vascular events
Antegrade ascending aortic dissection 1 0.9
Femoral artery problems 5 4.7
Pseudoaneurysm 2 1.9
Femoral artery embolism 1 0.9
NSR, Normal sinus rhythm; IABP, intra-aortic balloon pump.
Table V. Postoperative data (n = 106)
Recovery times
Ventilatory support
Mean (h) 8.9 ± 7.4
Median (h) 7.5
>12 h (patients) 23 (22%)
Intensive care unit stay
Mean (h) 31 ± 37
Median (h) 23
>48 h (patients) 9 (8%)
Hospital stay
Mean (d) 5.6 ± 3.0
<5 d (patients) 40 (38%)
>7 d (patients) 14 (13%)
Transfer to rehabilitation facility (patients) 7 (7%)
Return to “normal” activity
Mean (wk) 9.0 ± 8.5
Median (wk) 6
Pain control
Morphine intake*
Mean (mg) 7.3 ± 5.8
Median (mg) 6
In-hospital pain medicine intake*
Mean (tablets) 6.5 ± 5.2
Median (tablets) 6
Post-hospital pain medicine (patients) 
Never filled 43 (49%)
Filled but did not complete 40 (46%)
Completed 4 (5%)
*Total intake for the first 3 postoperative days.
angioplasty in the operating room. One of these
patients had postoperative ischemia in this leg, neces-
sitating operative thrombectomy, and another required
operative repair of a pseudoaneurysm. One other
patient had a small pseudoaneurysm that was success-
fully treated with ultrasound-guided compression. All
of the remaining patients had palpable distal pulses at
discharge and no further sequelae. One patient had an
acute thromboembolic event to the noncannulated leg,
which necessitated operative thrombectomy. One
patient had an antegrade dissection of the ascending
aorta in the operating room arising from the cardiople-
gia needle hole. The ascending aorta was replaced with
a tube graft by way of the same incision with the
patient under deep hypothermic circulatory arrest. He
recovered with no further complications.
Other morbidity. One patient required re-exploration
for bleeding from a branch of the right internal thoracic
artery, 1 had a temporary visual ischemic attack, and 2
had small strokes.
Length of stay. The mean length of stay in the hospital
was 5.6 ± 3 days versus 8.3 ± 6 for conventional surgery.
The primary reasons for prolonged length of stay in the
MI-MVS group appeared to be atrial fibrillation (Table
V). None of the 47 patients who remained in normal
sinus rhythm throughout their hospitalization had a pro-
longed length of stay, and the mean length of stay among
these patients was 4.5 days, more than 2 days shorter than
that of patients who had new atrial fibrillation. Only 7 of
106 patients required post-hospital rehabilitation, and 5
of these 7 were more than 75 years old. On average,
patients were able to return to their “normal” activities in
half the time required by patients with conventional
mitral valve operations performed through a sternotomy.
Surgical efficacy and late results. Surgical efficacy
was assessed by reviewing preoperative and postoper-
ative echocardiographic data and functional class. This
information is compiled in Table VII along with late
postoperative events.
Follow-up. Patient follow-up was 93% complete.
Mean follow-up time was 9 months.
Echocardiographic results. Among those patients
undergoing mitral valve repair for mitral regurgitation,
the mean score (0-4 scale) decreased from 3.7 to 0.7.
No patients undergoing mitral valve replacement were
found to have a perivalvular leak.
Late mortality. Two patients died during the follow-
up period. One patient died suddenly 8.5 months after
the operation. The other patient had multiple complica-
tions during her hospital stay, including a stroke that
left her incapacitated, and she died of pneumonia at a
rehabilitation facility 7 weeks after the operation.
Late events. One patient underwent reoperative
mitral valve replacement 3 months after the operation
for recurrent mitral regurgitation and hemolysis. This
was due to rupture of a second chorda. One visual tran-
sient ischemic attack occurred, but no frank strokes
were noted during late follow-up.
Discussion
The current interest in minimally invasive cardiac
surgery has been motivated by a desire to improve
patient outcomes by decreasing surgical trauma while
maintaining the quality of conventional cardiac surgery.
The precise definition of a “minimally invasive” ap-
proach and the best way to assess it and other risks and
benefits continue to evolve. The encouraging results
described herein do seem to indicate a significant bene-
fit to this approach. Nonetheless, several potential
issues remain to be addressed.
Patient population. The 106 patients in the study
group represent a fairly typical spectrum of adult
patients with mitral valve disease in the Western world.
They were a relatively young, generally healthy group
of patients with good left ventricular function who typ-
ically underwent elective mitral valve repair of a myx-
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Table VI. Impact of AF on hospital length of stay
Mean length of stay (d)
All patients 5.6 ± 3.0
Patients with preop NSR 5.1 ± 1.8
Patients continuing to have NSR 4.5 ± 0.9
Patients with new AF 6.6 ± 2.4
Patients with preop AF 6.4 ± 4.1
AF, Atrial fibrillation; NSR, Normal sinus rhythm.
Table VII. Surgical efficacy and late results
No. %
Mean follow-up time (mo) 8.9 ± 3.3 
Late deaths 2 1.9
Sudden death 1
Pneumonia 1
Reoperations 0.9
Thromboembolic events
Transient ischemic attack 1 0.9
Stroke 1
Echocardiographic results
Mitral valve repair
Preop MR (0-4) 3.8 ± 0.4
Postop MR (0-4) 0.7 ± 0.7
Mitral valve replacement
Perivalvular leak 0 0
Functional class (I-IV)
Preop 2.3 ± 0.5
Late postop 1.5 ± 0.8
MR, Mitral regurgitation.
omatous, regurgitant valve after having class II or III
symptoms. Although not a consecutive series, they rep-
resent the vast majority of patients undergoing isolated,
primary mitral valve surgery at our institution during
this time.
Potential sources of bias include the possibility that
the higher-risk patients were undergoing conventional
operations during this time and that the increased vol-
ume of surgery may have generated a referral bias by
attracting more low-risk patients. The 22 patients who
underwent conventional operations during this period
did so primarily as a result of surgeon preference.
Therefore, although it is difficult to characterize and
compare such a small group of patients, our impression
is that these patients were not a higher-risk group than
the MI-MVS group.
Technical considerations. The goal of our current
approach is to provide, through a limited incision, ade-
quate exposure of the valve to ultimately permit the use
of standard techniques of mitral valve repair and
replacement. Given the outstanding results of standard
mitral valve operations, especially valve repair proce-
dures,18-20 it seems difficult to justify compromising
the repair for the sake of a smaller incision.
Physical examination and good posteroanterior and
lateral chest x-ray films sufficed, in our experience. A
very obese or very muscular chest wall is not a good
setting for this approach. Obtaining exposure requires a
gradual, step-wise approach with liberal use of retrac-
tion sutures to rotate the valve into the field. Dividing
the right thoracic artery has been very useful in obtain-
ing exposure while minimizing the extent of cartilage
resection. Although division of this artery is not ideal,
none of these patients had coronary disease and they
are unlikely to need this conduit in the future. This
technique allows the detached ribs to be retracted later-
ally without avulsing the artery. Marsupializing the
pericardium to the dermis before inserting the retractor
has also been very helpful, especially in heavy patients.
Protecting the cross-sectional area of the primary
wound by passing cannulas and tourniquets through
separate stab incisions is helpful. Although each indi-
vidual item may not seem to be impeding the view, a
few items can quickly take up much of the working
area of the wound.
In a few patients in whom the third and fourth carti-
lages appeared to provide adequate exposure, but in
whom we encountered difficulties with femoral cannu-
lation, we extended the incision into the second carti-
lage to allow direct aortic cannulation. If the above
guidelines are followed, adequate exposure can be
obtained without violating 3 cartilages. Despite these
ing phase, no patient required conversion to sternoto-
my because of dissection at the cardioplegia port.
The 6 patients (6%) who had femoral artery complica-
tions in this series confirm that groin cannulation has
risks. These injuries were all amenable to local repair
during the mitral valve operation. Only 2 of these
patients, however, required operative reintervention (1
pseudoaneurysm repair and 1 thrombectomy). Whether
these localized injuries will result in late-term complica-
tions is not known. However, the ability to avoid a groin
incision altogether in most patients has been a major
advance in this technique. Advanced cannula technology
has permitted safe and effective direct aortic cannulation
and percutaneous femoral venous cannulation.
Early results. The operative mortality of 0% and the
excellent early echocardiographic results certainly attest
to the safety and efficacy of this approach, similar to
that of conventional mitral valve surgery.18-20 However,
the minimally invasive technique clearly required more
time in the operating room. The net increase in operat-
ing room time was about 65 minutes and can be mostly
accounted for by an extra 20 minutes of ischemic time
and an extra 45 minutes of CPB. The extra ischemic
time is the result of some additional technical maneu-
vers to enhance exposure. The extra CPB time is mostly
due to extra precautions necessary to properly remove
air from the heart by echocardiographic control.
Despite this increase in operative times, procedures
appear to accelerate all components of inpatient and
outpatient recovery, and we believe that this improve-
ment can be attributed to a cumulative effect of less
surgical trauma. Significantly shorter times for ventila-
tory support, intensive care unit stay, hospital stay, and
postdischarge return to normal activities were noted.
The rate of re-exploration for bleeding was gratifying-
ly low at 0.9% (1/106). This, as well as the decreased
transfusion requirement, again probably directly
reflects the benefits of decreasing surgical trauma and
dissection.
Tabulating the consumption of pain medication is a
relatively crude measure of pain control compared with
other more sophisticated techniques, which we have
not yet incorporated into our study. Nonetheless, the
significant decrease in inpatient pain medication use,
the fact that more than 50% of patients took no narcot-
ic pain medications after discharge, and the fact that
fewer than 5% finished their prescriptions are all con-
sistent with our impression that these patients have less
pain during their early postdischarge recovery.21
Although the incidence of new atrial fibrillation was
somewhat decreased in the MI-MVS group, it remains
a formidable problem that clearly limits our ability to
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shorten length of stay and decrease hospital costs with
this procedure, as previously documented.22 This is
demonstrated by the fact that all of the 47 patients who
remained in normal sinus rhythm were discharged by
the sixth postoperative day and that new atrial fibrilla-
tion added 2.1 hospital days and nearly $9000 in extra
hospital charges.
Other minimally invasive approaches. Other mini-
mally invasive approaches include video-assisted tech-
niques, Port-Access approaches, and direct-access
parasternal or ministernotomy incisions. Many of these
reports have been limited to a few patients and have con-
centrated on technical issues. However, a few groups
have collected large enough series to permit analysis of
the relative risks and benefits of each technique.
The first “minimally invasive” mitral repair has been
attributed to Carpentier’s group.3 They recently report-
ed on 22 patients in whom video-assisted mitral valve
surgery was performed through a 6- to 7-cm minitho-
racotomy or ministernotomy with the use of femoral
cannulation and video assistance. They reported 1 con-
version to sternotomy and 3 early reoperations—2 for
bleeding and 1 for recurrent mitral regurgitation. They4
have recently favored the hemisternotomy with video
assistance and have moved, as we have, toward direct
aortic cannulation combined with percutaneous
femoral venous cannulation.
Chitwood’s group5 has also advocated video-assisted
mitral surgery through a 6-cm anterior thoracotomy
using femoral cannulation and a new transthoracic aor-
tic clamp. In a series of 31 patients, they reported 1
operative death and some results that are similar to
ours, including higher operating room times followed
by accelerated postoperative recovery and decreased
costs when compared with historical controls.
The New York University group recently presented
encouraging results with Port-Access mitral valve
surgery using the Heartport system (Heartport, Inc,
Redwood City, Calif) with a 1.1% mortality and accel-
erated recovery in 130 patients.1 Mohr’s group2 from
Leipzig recently presented data on Port-Access mitral
valve surgery in 51 patients with an operative mortali-
ty of 10%, with 2 retrograde aortic dissections and 3
early perivalvular leaks.
Finally, Navia and Cosgrove13 and Cosgrove, Sabik,
and Navia14 were the first to popularize the parasternal
approach for the mitral valve and described 25 patients
in their limited report with techniques very similar to
the ones we have used in this series. Some differences
include the length of the incision (10 cm vs 6-8 cm),
complete resection of the costal cartilages (vs partial
resection with lateral mobilization through the inter-
costal spaces), and a more extensive atriotomy.
Cosgrove, Sabik, and Navia14 have recently changed
their approach to an upper sternotomy for mitral valve
surgery to “optimize exposure.”
Conclusions
By eliminating open femoral cannulation in most
patients and modifying the specific techniques of the
parasternal incision to avoid herniation and paradoxic
motion, the direct-access parasternal technique
described in this report might serve as a paradigm for
the future of minimally invasive mitral valve surgery.
Although future technologic and surgical advances will
continue to refine the technique, it currently appears to
strike a balance between minimizing surgical trauma,
by leaving the sternum completely intact, and providing
enough exposure to perform a meticulous mitral valve
operation without technical compromise. Our results
show that although this may add time in the operating
room, the patient ultimately benefits by recovering
more rapidly, leaving the hospital sooner, with a better
cosmetic result, less pain, and less exposure to blood.
The recuperation period is significantly shorter and
return to normal activities is quicker. Most important,
these benefits were accomplished while maintaining or
surpassing the surgical efficacy of conventional mitral
valve surgery.
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Discussion
Dr Alain F. Carpentier (Paris, France). This paper is a
significant contribution to minimally invasive mitral valve
surgery. The Brigham and Women’s Hospital group should be
congratulated for an innovative technique and for their
remarkable results. In particular, they have minimized the
parasternal approach and avoided an extensive incision of the
2 atria by approaching the mitral valve through the septum, as
we do. However, the parasternal approach is still too inva-
sive. In our institution we have been using the partial ster-
notomy and transseptal approach with similarly good results,
without the risk of lung hernia, the main disadvantage of
dividing the internal thoracic artery. Have you tried any of the
partial median sternotomy approaches with video assistance,
and what is your opinion of them? 
Second, I agree with you that aortic cannulation should be
preferred to femoral cannulation. Of course, the cannula
obscures somewhat the operative field, but in compensation,
you can avoid cannulating the superior vena cava by using
the double-staged venous cannula developed by DLP, Inc
(Walker, Mich), which provides an excellent drainage of the
2 venae cavae through this single cannula introduced through
the ileac vein up to the superior vena cava. 
Third, you have obtained excellent short-term results with
no mortality and a low degree of residual mitral regurgitation.
Rather than telling us the residual regurgitation score, it
would be more informative to tell us how many cases of 0,
1+, or 2+ residual regurgitation you observed. 
I raise this important question because one of the risks of
minimally invasive mitral valve surgery is to perform a less
optimal repair, favoring, for example, a less durable posteri-
or support of the posterior leaflet rather than a complete
remodeling of the anulus whenever necessary. I do not recall
any data comparing residual insufficiency in patients having
minimally invasive operations and those undergoing conven-
tional techniques.
Another risk of minimally invasive mitral valve surgery is
the temptation to favor valve replacement instead of valve
repair. I noticed that in the period between January and June
1997, you had a proportion of approximately 10% valve
replacements versus 90% valve repairs, which is very good,
but during the following 6-month period the proportion of
valve replacements rose to approximately 17%. Does that
mean that you experienced some disenchantment? 
Your data comparing minimally invasive surgery to con-
ventional surgery in terms of postoperative recovery, ventila-
tory support time, and intensive care unit and hospital stay
were impressive; however, there may be a bias in this regard
since the fast-track policy began at approximately the same
time as minimally invasive surgery. Do you think that the dif-
ference you showed would be less impressive today with the
fast-track conventional surgery used in most institutions? 
Finally, I agree with you that minimally invasive surgery is
feasible with excellent results. However, minimally invasive
mitral valve surgery is more difficult than aortic valve
surgery and carries on a risk of suboptimal valve repair,
which has not been the case in your study. 
Dr Aklog. Thank you, Dr Carpentier. We did sacrifice the
right internal thoracic artery in all of these patients. The risk
of infection has not been a problem. More important, be-
cause these patients all have normal coronary arteries, it is
extremely unlikely that they will need the internal thoracic
artery as a potential conduit in the future. We believe that
dividing the right internal thoracic artery does help with
mobilization by allowing greater retraction of the lateral
aspect of the wound while minimizing the amount of resected
cartilage. 
We have not tried a partial sternotomy approach for mitral
valve surgery. However, we have used this approach exten-
sively for aortic valve surgery.
You commented on the double-staged venous cannula,
which avoids the need for a superior vena cava cannula. I
have seen that in your report. I think it will be a helpful con-
tribution to this approach. Any item that can be removed from
the main wound does improve exposure and consequently
improves the ease of the operation. 
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You asked about the relative proportion of patients who had
different degrees of residual mitral regurgitation after repair.
Two patients had 3+/4+ mitral regurgitation. One of these
patients underwent reoperation, as described. Ten patients had
2+/4+ mitral regurgitation, and the rest of them had 0 or 1+/4.
The patients having minimally invasive operations actually had
a slightly lower score, but the difference was not statistically sig-
nificant. Therefore one major point that we wanted to convey
was that this exposure provides an excellent view of the valve
and allows the operation to be done in the conventional way with
standard instruments. The limited exposure did not compromise
the repair in any way. Our data indicate that we were able to
maintain the efficacy of the conventional mitral valve repair. 
We did not favor replacement over repair in the minimally
invasive group. I think the figure you are referring to is the
one comparing the rate of minimally invasive versus conven-
tional surgery. The proportion of repairs has remained about
the same during the minimally invasive period and was, in
fact, significantly higher than in the conventional group. 
Our fast-track program was in place before treatment of the
control group was begun. Clearly this is a historical control
group and contains the usual limitations of such a group.
However, I do not think the differences in fast-track policy
were a major factor in explaining our encouraging results.
Although even after the initiation of our fast-track program,
there has been ongoing pressure to get patients out of the hos-
pital, we do not think this can account for the significant
decrease in length of stay seen in these patients. We, in fact,
evaluated whether there were comparable decreases in stay
for other operations, such as routine coronary procedures,
and found that the magnitude of the decrease was small com-
pared with what we saw with the initiation of minimally inva-
sive mitral valve surgery. Again, within the limitations of a
historical control group, we think that the patients undergo-
ing minimally invasive operations did recover more rapidly.
Dr David B. Skinner (New York, NY). In view of the
importance of bilateral internal thoracic artery grafting, is it
necessary to divide the right internal thoracic artery? 
Second, your abstract listed 100 patients and your article,
106. What is the reason for this discrepancy?
Dr Aklog. We added 6 additional patients from the date of
the abstract to December 31, 1997.
We have, over time, decreased the amount of cartilage
resected to decrease the potential problem with wound herni-
ation. One of our techniques to accomplish this is to incise
through the intercostal space above and below, quite laterally.
This allows the incision to open up laterally like an open
book. To accomplish that without the potential of avulsing
the thoracic artery during retraction, we have to divide the
artery at the 2 intercostal spaces. As I said, these patients have
no coronary disease. If we were sacrificing the left internal
thoracic artery, we would be more concerned. However, with
the right, we have taken the gamble that these patients are not
going to need it as a conduit in the future.
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